Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies 10X Fund, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Khurram Jamil - $1.44M in GALT purchases and sales in the last 12 months
- Jack W. Callicutt - $944K in GALT purchases and sales in the last 12 months
- Joel Lewis - $621K in GALT purchases and sales in the last 12 months
- Harold H. Shlevin - $501K in GALT purchases and sales in the last 12 months
- Kevin D. Freeman - $20K in GALT purchases and sales in the last 12 months
- Kary Eldred - $3K in GALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
- 1315 Capital II, L.P.
- 1RT Acquisition Sponsor LLC
- 2013 Trust fbo Evelyn R. Kuipers
- 2018 Reed Dynasty Trust
- 2023 Grantor Retained Annuity Trust of Agnes C. Kim Dated 4/26/2023
- 2023 Grantor Retained Annuity Trust of James J. Kim Dated 4/26/2023
- 2023 Grantor Retained Annuity Trust of Susan Y. Kim Dated 9/15/2023
- 2024 Grantor Retained Annuity Trust of Agnes C. Kim dtd. 8/5/2024
Frequently asked questions
What is 10X Fund, L.P.?
10X Fund, L.P. is an investment firm, tracked as 10% Owner of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 5 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did 10X Fund, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 18 December 2025, one of 5 filings going back to 2025.
Has 10X Fund, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.43M) across all tracked filings.
